Mutual Fund Details
NAV
₹44.0180
as on 14 Jul 2025, 09:00 PM
₹0.5110(1.17%)
Last Change
Scheme Ratings
1
Pharma
5Y Returns
4
rated by Value Research
Pharma
Rankings based on 5Y Returns | as on 18 Nov 2024
×
1
DSP Healthcare Fund Direct - Growth
24.84%
2
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
25.54%
3
Mirae Asset Healthcare Fund Direct - Growth
24.11%
4
SBI Healthcare Opportunities Fund Direct Plan-Growth
25.29%
5
UTI Healthcare Fund Direct-Growth
23.26%
Schemes Managed By
Download the Paytm Money app now!
Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.
Zero brokerage for 30 days- Zero account opening fees
- Zero AMC for life
Scan QR code to download the app
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,97,397
₹2,05,532
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹1,05,532
Profit (absolute return)
105.53%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
9.54%
In the last 6 months
3.03%
In the last 1 year
13.27%
In the last 3 years
105.53%
In the last 5 years
203.57%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
DSP Healthcare Fund Direct - Growth
as of 30 Jun 2025, 05:30 AM
₹3,056.90 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.50% if redeemed within 1 month.
0.58%
Expense Ratio
Plan
Growth
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Scheme Document
Sectors Holding in this Mutual Fund
as on 30 Jun 2025
Healthcare
96.70%
₹2,956.03 Cr
Insurance
1.61%
₹49.22 Cr
Others
1.69%
₹51.66 Cr
Companies Holding in this Mutual Fund
as on 30 Jun 2025
Cipla Ltd.
8.86%
₹270.84 Cr
Cohance Lifesciences Ltd.
8.81%
₹269.31 Cr
Sun Pharmaceutical Industries Ltd.
8.70%
₹265.95 Cr
Ipca Laboratories Ltd.
8.16%
₹249.44 Cr
Gland Pharma Ltd.
4.94%
₹151.01 Cr
Others
60.53%
₹1,850.34 Cr
View All
View All
This fund's returns:
27.12%Return Duration
3 Years
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
19.23%
29.79%
3Y Returns
29.79
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.23%
29.79%
3Y Returns
29.48
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.23%
29.79%
3Y Returns
27.34
About DSP Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Chirag Dagli. It has an AUM of ₹3,056.90 Crores and the latest NAV decalared is ₹44.018 as on 15 Jul 2025 at 1:03 pm.
DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 13.27%, in last 3 years is 105.53% and 332.73% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹3,056.90 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
DSP Mutual Fund
View AMC Details
₹2,05,550.93 Cr
AUM
171
Schemes
Address
The Ruby, 25th Floor29, Senapati Bapat Marg,Dadar (West), Mumbai400028
Phone Number
Phone : +91 22 6657 8000
Fax : 022-56578181
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
